Investing in the future of healthcare requires more than breakthrough science alone.
Two major UK initiatives announced this year highlight how coordinated funding, cross-sector collaboration and long-term skills development are converging to accelerate innovation while ensuring it reaches patients.
A new £5m programme led by CPI and funded by the Office for Life Sciences aims to tackle one of the most persistent challenges in oncology: late diagnosis.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.